To Evaluate the Safety and Pharmacokinetics of BMS-986177 in Healthy Japanese Participants
NCT03224260
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
33
Enrollment
INDUSTRY
Sponsor class
Conditions
Thrombosis
Interventions
DRUG:
BMS-986177
OTHER:
Matched Placebo
Sponsor
Bristol-Myers Squibb